Summary
An unbiased approach to map the sentinel lymph node landscape reveals progressive immune dysfunction associated with micrometastasis in patients with stage I–III cutaneous melanoma. Evidence of tumor-induced lymph node dysfunction may motivate new hypotheses for neoadjuvant therapy with potential to reinvigorate endogenous antitumor immunity.
See related article by Yaddanapudi et al., p. 2069
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
You do not currently have access to this content.